BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11753646)

  • 1. Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas.
    Chen W; Palanisamy N; Schmidt H; Teruya-Feldstein J; Jhanwar SC; Zelenetz AD; Houldsworth J; Chaganti RS
    Oncogene; 2001 Nov; 20(52):7686-93. PubMed ID: 11753646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
    Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
    Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
    Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples.
    Einerson RR; Kurtin PJ; Dayharsh GA; Kimlinger TK; Remstein ED
    Am J Clin Pathol; 2005 Sep; 124(3):421-9. PubMed ID: 16191511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
    Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
    Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B.
    Bosga-Bouwer AG; Haralambieva E; Booman M; Boonstra R; van den Berg A; Schuuring E; van den Berg E; Kluin P; Poppema S
    Genes Chromosomes Cancer; 2005 Nov; 44(3):301-4. PubMed ID: 16075463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptic IGH/BCL2 rearrangements with variant FISH patterns in follicular lymphoma.
    Baró C; Espinet B; Salido M; García M; Sánchez B; Florensa L; Bellosillo B; Serrano S; Solé F
    Leuk Res; 2011 Feb; 35(2):256-9. PubMed ID: 20952062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.
    Lestou VS; Ludkovski O; Connors JM; Gascoyne RD; Lam WL; Horsman DE
    Genes Chromosomes Cancer; 2003 Apr; 36(4):375-81. PubMed ID: 12619161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
    Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of BCL2 translocation in an interphase neucleus using fluorescence in situ hybridization strategy].
    Sun Y; Han X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):472-5. PubMed ID: 11774219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation.
    Schraders M; de Jong D; Kluin P; Groenen P; van Krieken H
    J Pathol; 2005 Feb; 205(3):329-35. PubMed ID: 15682435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
    Masir N; Campbell LJ; Jones M; Mason DY
    Pathology; 2010 Apr; 42(3):212-6. PubMed ID: 20350212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
    Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
    Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma.
    Nomura K; Kanda-Akano Y; Shimizu D; Okuda T; Yoshida N; Matsumoto Y; Nishida K; Taki T; Yokota S; Horiike S; Taniwaki M
    Ann Hematol; 2005 Jul; 84(7):474-6. PubMed ID: 15700138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.
    Torlakovic EE; Aamot HV; Heim S
    J Pathol; 2006 Jun; 209(2):258-64. PubMed ID: 16583359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique three-way translocation, t(3;14;18)(q27;q32;q21), in follicular lymphoma.
    Okano A; Nakano S; Namura K; Yamada N; Uchida R; Fuchida S; Okamoto M; Ochiai N; Shimazaki C
    Cancer Genet Cytogenet; 2005 Jun; 159(2):174-6. PubMed ID: 15899393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.
    Callanan MB; Le Baccon P; Mossuz P; Duley S; Bastard C; Hamoudi R; Dyer MJ; Klobeck G; Rimokh R; Sotto JJ; Leroux D
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):309-14. PubMed ID: 10618414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant t(14;18) in malignant lymphoma: a report of seven cases.
    Bentley G; Palutke M; Mohamed AN
    Cancer Genet Cytogenet; 2005 Feb; 157(1):12-7. PubMed ID: 15676141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.